about
[Melanoma brain metastases : Treatment options].The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis.Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study.Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study.Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].[Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary AdenomaEfficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastomaIntraspinal intradural nodular fasciitis mimicking glioblastoma metastasis: a case reportTumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGFActively personalized vaccination trial for newly diagnosed glioblastomaIdentification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaImmunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasisHigh frequency of H3 K27M mutations in adult midline gliomasChallenges and opportunities in meningiomas: recommendations from the International Consortium on MeningiomasOncogenic KRAS hotspot mutations are rare in IDH-mutant gliomasA Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastomaLomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialCOX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intakePosterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy[Challenges and future perspectives in neuro-oncology]Regorafenib in advanced high-grade glioma: a retrospective bicentric analysisBaseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialIntegrative assessment of brain and bone invasion in meningioma patientsRetrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomasGlioblastoma: State of the Art and Future PerspectivesIdentification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaWithdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma[Neuro-Oncology]Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway AnalysisHealth-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
P50
Q31098294-5092A67D-8DD5-4035-88D5-B4A0857BD3D9Q38669337-ED345A8F-99A2-4D60-8DCC-77EFBFC2A3CCQ38765212-8795B41E-AC20-4FEF-AAD4-51BC60515E3FQ38866245-7420AAF3-8295-4432-937F-D794BDDE8EA1Q38962335-18DC7184-B3D1-4C24-9BE2-83FBED34CBCBQ38981263-DB7ECE11-DE97-4943-B536-78799588DFADQ39253274-F1853676-F389-4951-ABF2-5E605D7D7A3CQ47592896-BD27B913-7575-4ED6-A480-8FDC6835442DQ53473766-63BE14B0-D00B-446E-BB9C-BC91872765FDQ53830664-8F1CE265-8424-435D-A5A8-77D85C82087FQ55460811-9FEB23B2-055F-4025-BAA9-97EB39D1579DQ55460812-DF01F76D-9384-4B9C-A5FE-FECA6979876CQ60907459-7DEA5E34-FA45-4782-BFF2-025B69B87406Q64094581-44CDBC74-4693-489E-934D-3C515D8C6F43Q88382929-2072062C-35AE-4604-A7F4-5DD7D201420BQ90615800-650E76F9-300A-476E-9C7E-9A81E4ED56B8Q90648467-493105AC-9554-4BFE-B67D-D0B8CF3BF2D1Q90722961-42466FC1-696A-4F6E-8C75-54231933BE23Q90867134-EBDE8ED2-D1E8-4E5B-94D2-24E27CB55F0AQ90895396-A59494D0-75C5-4AF3-8516-31570F77302EQ91072502-4F0482F2-7D58-4351-AB8B-5B5BC9FD4B7FQ91195022-47E085FC-E01E-4092-B61B-C5A6C1276393Q91499062-BF3C1C9F-7B69-474F-939B-DC96F759917DQ91721428-4CF95765-979B-490B-8131-3DBC8B26E6FBQ91774084-2ACDC8D6-067B-4171-ABDA-9406E890651CQ91785809-2D9EB1C9-2E8C-454A-8D8F-DCCB9B254FF1Q91904086-AFC6654A-27EE-457B-AE89-538AB3873ACEQ92026414-93273B23-B2A7-4E5F-A8C5-1D8B13CE03F9Q92037929-1696D941-7D1E-443B-B4B4-897544EF264BQ92260690-A9125FBD-D9DF-4E5F-8E92-BC5966C300F2Q92283446-DD11ADC1-03A7-4797-B026-543DEDF29CE3Q92344401-A1184A79-55E4-4F3C-BFF4-71D4446A7469Q92466014-3ABBAB85-D3E0-41FD-B001-CA2B9C796135Q92466028-D5796446-A4B2-484B-ADFD-930680529A0CQ92596962-24804023-6D41-41D0-9FA5-51E47EBF12ABQ92637203-695C0BF7-521D-4C22-A0E8-B1FBCA80BC66Q93130392-EC32FC11-D055-41B3-91D4-99474E442268
P50
description
German neurologist
@en
German neurologist
@en-ca
German neurologist
@en-gb
deutsche Neurologin
@de
neuróloga alemana
@es
wetenschapper
@nl
طبيبة أعصاب ألمانية
@ar
name
Ghazaleh Tabatabai
@de
Ghazaleh Tabatabai
@en
Ghazaleh Tabatabai
@fr
Ghazaleh Tabatabai
@nl
type
label
Ghazaleh Tabatabai
@de
Ghazaleh Tabatabai
@en
Ghazaleh Tabatabai
@fr
Ghazaleh Tabatabai
@nl
prefLabel
Ghazaleh Tabatabai
@de
Ghazaleh Tabatabai
@en
Ghazaleh Tabatabai
@fr
Ghazaleh Tabatabai
@nl
P227
P106
P21
P227
P31
P496
0000-0002-3542-8782
P569
1974-02-11T00:00:00Z